中国药物性肝损伤首个网站“HepaTox”正式发布

发布时间：2018-05-13 07:53

本文选题：药物性肝损伤 + HepaTox　；参考：《上海交通大学学报(医学版)》2014年06期

【摘要】：正2014年6月14日,由中华医学会肝病学分会药物性肝病学组主办,《肝脏》杂志和上海交通大学医学院附属仁济医院承办的"2014中美药物性肝损伤论坛暨中国药物性肝损伤专业网站HepaTox发布会"顺利举行。中国药物性肝损伤(DILI)首个专业网络平台"HepaTox"(http://www.hepatox.org/)在此次会议上正式公布运行,这是继2012年美国"LiverTox"网站运行后全球第二个专注于DILI的网络平台。美国药物性肝损伤网络协作组织主席、北卡罗来纳大学Paul Watkins教授亲临祝贺。
[Abstract]:On 14 June 2014, Sponsored by the Drug liver Disease Section of the Chinese Medical Association, the Journal of liver Science and Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine, the forum on drug-induced liver injury between China and the United States and the China Drug induced liver injury (HepaTox) website in 2014 The press conference was held smoothly. "HepaTox", the first professional online platform for drug-induced liver injury in China, was officially launched at the conference at http- / www.hepatox.org. this is the second dedicated DILI platform in the world following the 2012 launch of the U.S. "LiverTox" website. Professor Paul Watkins of the University of North Carolina, President of the Drug-induced liver injury Network, is here to congratulate you.
【分类号】：+

【相似文献】